Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qianlie Bier Tong suppository for chronic nonbacterial prostatitis (damp-heat and blood stasis pattern)
CTR20260027Phase 3Active
- Sponsor
- Heilongjiang Jiren Pharmaceutical
- Start
- Apr 2026
- Countries
- 1
01
Overview
A Phase 3 trial of Qianlie Biertong in Prostatodynia (CP/CPPS), sponsored by Heilongjiang Jiren Pharmaceutical. Started Apr 2026; status: active.
02
Drugs
Qianlie Biertong
03
Conditions
Prostatodynia (CP/CPPS)
Beyond the preview
Go deeper on CTR20260027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260027.